Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SoSTART: Start or Stop Anticoagulants After Spontaneous Intracranial Haemorrhage
2016-004121-16Phase 3Unknown
- Sponsor
- University of Edinburgh
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of apixaban, rivaroxaban, edoxaban, dabigatran, warfarin and 2 more in intracerebral hemorrhage (ICH), Atrial fibrillation (AFib) and cardiac morbidity (2 arms), sponsored by University of Edinburgh. Primary endpoint: Participant recruitment rate per site. Status: unknown.
02
Drugs
apixabanrivaroxabanedoxabandabigatranwarfarin
03
Conditions
intracerebral hemorrhage (ICH)Atrial fibrillation (AFib)cardiac morbidity
Beyond the preview
Go deeper on 2016-004121-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004121-16.